Literature DB >> 23294932

High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment.

Grégory Dubourg1, Jean-Christophe Lagier, Fabrice Armougom, Catherine Robert, Gilles Audoly, Laurent Papazian, Didier Raoult.   

Abstract

The gut microbiota is mainly composed of the phyla Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria; the Verrucomicrobia phylum is occasionally observed. Antibiotics can change the bacterial diversity of the gut, with limited changes in the proportions of phyla. In this study, the gut repertoire of two patients who received a broad-spectrum antibiotic regimen was studied. As part of a large gut microbiota study, two stool samples were analysed: one sample was collected after broad-spectrum antibiotic therapy in a patient with Coxiella burnetii vascular infection (Patient A); and the other sample was collected from a patient admitted to the Intensive Care Unit (Patient B). Samples were subjected to Gram staining, electron microscopy, 16S rRNA V6 amplicon pyrosequencing and fluorescence in situ hybridisation (FISH). In parallel, the antibiotic susceptibility of Akkermansia muciniphila Muc(T) strain was studied and this strain was observed by electron microscopy. Pyrosequencing revealed that a large proportion of the sequences were associated with Verrucomicrobia (proportions of 44.9% and 84.6% for Patients A and B, respectively). All of the phylotypes were represented by a single species (A. muciniphila), and neither patient presented significant gastrointestinal disorders. Electron microscopy and FISH with specific Verrucomicrobia probes confirmed the presence of the bacterium. The Muc(T) strain was susceptible to imipenem and doxycycline but resistant to vancomycin and metronidazole. Dramatic colonisation of the human gut microbiota by the Verrucomicrobia phylum following a broad-spectrum antibiotic regimen occurred without significant gastrointestinal manifestations, suggesting that influenced by external factors such as antibiotics, the gut repertoire remains partially unknown.
Copyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294932     DOI: 10.1016/j.ijantimicag.2012.10.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  76 in total

1.  Penicillin Trunk Injection Affects Bacterial Community Structure in Citrus Trees.

Authors:  Marina S Ascunce; Keumchul Shin; Jose C Huguet-Tapia; Ravin Poudel; Karen A Garrett; Ariena H C van Bruggen; Erica M Goss
Journal:  Microb Ecol       Date:  2018-12-01       Impact factor: 4.552

2.  Culturomics identified 11 new bacterial species from a single anorexia nervosa stool sample.

Authors:  A Pfleiderer; J-C Lagier; F Armougom; C Robert; B Vialettes; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

3.  Molecular studies neglect apparently gram-negative populations in the human gut microbiota.

Authors:  Perrine Hugon; Jean-Christophe Lagier; Catherine Robert; Catherine Lepolard; Laurent Papazian; Didier Musso; Bernard Vialettes; Didier Raoult
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

4.  The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota.

Authors:  Jean-Christophe Lagier; Perrine Hugon; Saber Khelaifia; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation.

Authors:  Ting Zhang; Pan Li; Xia Wu; Gaochen Lu; Cicilia Marcella; Xinghui Ji; Guozhong Ji; Faming Zhang
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-16       Impact factor: 4.813

6.  Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies.

Authors:  Kequan Zhou
Journal:  J Funct Foods       Date:  2017-03-29       Impact factor: 4.451

7.  Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells.

Authors:  Monica Bodogai; Jennifer O'Connell; Ki Kim; Yoo Kim; Kanako Moritoh; Chen Chen; Fedor Gusev; Kelli Vaughan; Natalia Shulzhenko; Julie A Mattison; Catalina Lee-Chang; Weixuan Chen; Olga Carlson; Kevin G Becker; Manoj Gurung; Andrey Morgun; James White; Theresa Meade; Kathy Perdue; Matthias Mack; Luigi Ferrucci; Giorgio Trinchieri; Rafael de Cabo; Evgeny Rogaev; Josephine Egan; Jiejun Wu; Arya Biragyn
Journal:  Sci Transl Med       Date:  2018-11-14       Impact factor: 17.956

8.  The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics.

Authors:  G Dubourg; J C Lagier; F Armougom; C Robert; I Hamad; P Brouqui; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-06       Impact factor: 3.267

Review 9.  Pathways in microbe-induced obesity.

Authors:  Laura M Cox; Martin J Blaser
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

10.  Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice.

Authors:  Yuqiu Han; Xiangyang Jiang; Qi Ling; Li Wu; Pin Wu; Ruiqi Tang; Xiaowei Xu; Meifang Yang; Lijiang Zhang; Weiwei Zhu; Baohong Wang; Lanjuan Li
Journal:  Front Med       Date:  2019-05-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.